GO:0045765 regulation of angiogenesis: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045765 regulation of angiogenesis is defined as any process that modulates the frequency, rate or extent of angiogenesis, the formation of new blood vessels from pre-existing vasculature.
• The term sits at the center of a dense regulatory network that includes hypoxia and the HIF system, peptide hormones, catecholamines, small GTPases, platelets, microRNAs and other non-coding RNAs [1,2,3,4,5,6,7].
• Dysregulated regulation of angiogenesis is a hallmark of cancer, wound healing disorders, retinopathies and ischemic disease, making it a major therapeutic target [1,2,3,6].
• Key molecular players include VEGFA, HIF1A, EPAS1, FLT1, KDR, ANGPT1, ANGPT2, TEK, PGF, FGF2, TGFB1, THBS1, and the Rap1 GTPase encoded by RAP1A/RAP1B [4,5,6,7].
• CRISPR knockout, point-mutation, knock-in and overexpression cell models, combined with CRISPR library screening and bioinformatics, are powerful tools for dissecting this regulatory process [1,2].
• Understanding GO:0045765 requires integrating transcriptional, post-transcriptional and signaling layers, since non-coding RNAs, hormones and platelet-derived factors all converge on the angiogenic endothelium [1,2,3,4,7].
Description
Angiogenesis is the process by which new blood vessels sprout from the existing vascular network, and it is essential for development, tissue repair and tumor growth. The Gene Ontology term GO:0045765, regulation of angiogenesis, captures any process that modulates the frequency, rate or extent of angiogenesis, thereby providing a formal framework for describing the many positive and negative inputs that control vessel formation. Because angiogenesis must be tightly balanced, its regulation involves a complex interplay of oxygen-sensing pathways, growth factors, hormones, adhesion molecules and non-coding RNAs [1,2,3,4,5,6,7]. For researchers, GO:0045765 is a useful organizing concept because it groups together mechanistically diverse regulators that all converge on the angiogenic endothelium. The HIF system responds to hypoxia and drives expression of pro-angiogenic factors such as VEGFA, while peptide hormones and catecholamines provide systemic and local signals that fine-tune vessel growth [3,4]. Small GTPases such as Rap1 and platelet-derived factors further modulate endothelial cell behavior and vessel stability [5,7]. In cancer and other diseases, these regulatory circuits are frequently rewired, making GO:0045765 a high-value target for mechanistic and translational studies [1,2]. This article summarizes the authoritative definition of GO:0045765, the major biological steps it encompasses, the genes and proteins most often studied in this context, and the experimental methods, including CRISPR-based approaches, that are used to interrogate it. All statements are grounded in the verified literature cited throughout.
regulation of angiogenesis At A Glance
| GO ID | GO:0045765 |
|---|---|
| GO term | regulation of angiogenesis |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Definition | Any process that modulates the frequency, rate or extent of angiogenesis. |
| Major function | Controls the balance of pro- and anti-angiogenic signals that determine new blood vessel formation. |
| Key upstream inputs | Hypoxia and the HIF system, peptide hormones, catecholamines, small GTPases, platelets, microRNAs and other non-coding RNAs. |
| Representative regulators | VEGFA, HIF1A, EPAS1, FLT1, KDR, ANGPT1, ANGPT2, TEK, PGF, FGF2, TGFB1, THBS1, RAP1A/RAP1B. |
| Disease relevance | Cancer, wound healing disorders, retinopathies, ischemic disease and other angiogenesis-dependent conditions. |
What Is GO:0045765?
GO:0045765 regulation of angiogenesis is a biological process term defined as any process that modulates the frequency, rate or extent of angiogenesis. In other words, it does not describe the construction of a blood vessel itself, but rather the control layer that decides when, where and how much angiogenesis occurs. This includes positive regulation (pro-angiogenic signals) and negative regulation (anti-angiogenic signals), as well as the integration of oxygen availability, growth factor signaling, hormonal cues and cell-intrinsic programs that collectively set the angiogenic set point [1,2,3,4,5,6,7].
Why Is regulation of angiogenesis Important in Cell Biology?
GO:0045765 is important because angiogenesis is a fundamental process in development, tissue repair and disease, and its regulation determines whether new vessels form appropriately or pathologically. Hypoxia-driven HIF signaling, peptide hormones, catecholamines, small GTPases, platelets and non-coding RNAs all converge on this regulatory node, so understanding GO:0045765 provides a systems-level view of how the vasculature is controlled [1,2,3,4,5,6,7]. In cancer, tumors hijack these regulatory circuits to sustain growth, and in wound healing or ischemic disease, insufficient or excessive regulation can impair repair or drive pathology [1,2,3,6]. Consequently, genes and pathways annotated to GO:0045765 are actively pursued as therapeutic targets and as biomarkers.
• Angiogenesis regulation is essential for normal development, wound healing and tissue regeneration [3,6].
• Tumors depend on deregulated angiogenesis regulation to grow and metastasize, making GO:0045765 a core cancer biology term [1,2].
• Hypoxia and the HIF system are central upstream regulators of angiogenesis, linking oxygen sensing to vessel growth.
• Peptide hormones and catecholamines provide systemic and local control of angiogenesis in wound healing and other contexts [3,4].
• Small GTPases such as Rap1 and platelet-derived factors modulate endothelial cell behavior and vessel stability [5,7].
• MicroRNAs and other non-coding RNAs add a post-transcriptional layer of angiogenesis regulation in cancer and other diseases [1,2].
• Dysregulated angiogenesis regulation contributes to retinopathies, inflammatory diseases and ischemic disorders [1,6].
• GO:0045765 provides a standardized annotation framework for comparing angiogenesis regulators across species and experiments.
• CRISPR-based knockout, knock-in and overexpression models enable causal testing of candidate regulators within this term [1,2].
• Therapeutic strategies targeting angiogenesis regulation include anti-VEGF agents and HIF-pathway modulators.
What Happens During regulation of angiogenesis?
Oxygen sensing and HIF-mediated transcriptional control
In simple terms: When cells lack oxygen, they switch on a master regulator that tells the body to build new blood vessels.
The HIF system is a primary upstream regulator of angiogenesis. Under hypoxia, HIF transcription factors stabilize and activate a broad transcriptional program that includes pro-angiogenic factors such as VEGFA, thereby increasing the frequency and extent of angiogenesis. This oxygen-sensing layer is a canonical example of how GO:0045765 integrates environmental cues into vessel growth control.
Peptide hormone and catecholamine signaling
In simple terms: Hormones and stress signals act like dials that can turn blood vessel growth up or down.
Peptide hormones regulate angiogenesis through receptor-mediated signaling pathways that modulate endothelial cell proliferation, migration and survival. In cutaneous wound healing, catecholamines provide additional regulatory input that influences the timing and magnitude of angiogenesis. Together, these hormonal and neuroendocrine signals contribute to the fine-tuning of GO:0045765 in physiological and pathological settings [3,4].
Small GTPase and platelet-mediated modulation
In simple terms: Small molecular switches and blood platelets help decide how stable and how extensive new vessels become.
The small GTPase Rap1 regulates angiogenesis by controlling endothelial cell adhesion, junction formation and sprouting behavior. Platelets also play a functional role in angiogenesis regulation by releasing pro- and anti-angiogenic factors that act on the endothelium. These mechanisms illustrate how cell-intrinsic switches and circulating cell-derived signals converge within GO:0045765 [5,7].
Non-coding RNA and post-transcriptional control
In simple terms: Tiny RNA molecules can fine-tune how much pro- or anti-angiogenic protein is made.
MicroRNAs and other non-coding RNAs regulate angiogenesis by targeting mRNAs encoding angiogenic factors and their receptors, thereby adding a post-transcriptional layer of control [1,2]. In cancer, altered expression of these non-coding RNAs can shift the angiogenic balance and promote tumor vascularization [1,2]. This layer is increasingly recognized as a key component of GO:0045765 [1,2].
Endothelial-dependent regulatory mechanisms
In simple terms: The cells lining blood vessels have their own internal control systems that adjust vessel growth.
Endothelial-dependent regulation of angiogenesis involves intracellular signaling and metabolic pathways within endothelial cells that respond to external cues and modulate sprouting, proliferation and barrier function. These endothelial-intrinsic mechanisms are essential for translating systemic and local signals into coordinated vessel formation within GO:0045765.
Key Genes Involved in GO:0045765 regulation of angiogenesis
The following genes and proteins are representative regulators annotated to or mechanistically linked with GO:0045765, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGFA | Principal pro-angiogenic growth factor induced by hypoxia | Central target in angiogenesis regulation studies and anti-angiogenic therapy |
| HIF1A | Oxygen-sensitive transcription factor driving pro-angiogenic gene expression | Key upstream regulator of GO:0045765 in hypoxia and cancer |
| EPAS1 | HIF-2alpha paralog contributing to hypoxia-driven angiogenesis | Studied for context-dependent regulation of vessel growth |
| FLT1 | VEGF receptor 1 that modulates VEGF availability and signaling | Important for fine-tuning angiogenic responses |
| KDR | VEGF receptor 2 mediating major pro-angiogenic signaling | Core receptor in endothelial angiogenesis regulation |
| ANGPT1 | Angiopoietin 1 stabilizing vessels and reducing permeability | Studied for vessel maturation and stabilization |
| ANGPT2 | Angiopoietin 2 destabilizing vessels and promoting sprouting | Context-dependent regulator of angiogenesis |
| TEK | TIE2 receptor for angiopoietins controlling vessel stability | Key node in endothelial angiogenic signaling |
| PGF | Placental growth factor modulating VEGF signaling | Studied in pathological angiogenesis |
| FGF2 | Fibroblast growth factor 2 promoting endothelial proliferation | Alternative pro-angiogenic pathway |
| TGFB1 | Transforming growth factor beta 1 with context-dependent angiogenic effects | Studied for dual pro- and anti-angiogenic roles |
| THBS1 | Thrombospondin 1 acting as an endogenous anti-angiogenic factor | Model anti-angiogenic regulator |
| RAP1A | Small GTPase regulating endothelial adhesion and sprouting | Mechanistic studies of Rap1 in angiogenesis |
| RAP1B | Rap1 paralog contributing to endothelial signaling | Studied alongside RAP1A in angiogenesis regulation |
| CD36 | Scavenger receptor mediating anti-angiogenic signals | Studied in thrombospondin-dependent regulation |
| NOS3 | Endothelial nitric oxide synthase modulating vascular tone and angiogenesis | Downstream effector of angiogenic signaling |
| PTK2 | Focal adhesion kinase involved in endothelial migration | Studied in sprouting angiogenesis |
How Is regulation of angiogenesis Regulated?
Regulation of angiogenesis (GO:0045765) is itself controlled at multiple levels. The HIF system provides transcriptional control in response to hypoxia, directly linking oxygen availability to pro-angiogenic gene expression. Peptide hormones and catecholamines add endocrine and neuroendocrine inputs that modulate endothelial behavior [3,4]. Small GTPases such as Rap1 and platelet-derived factors act at the level of cell adhesion, signaling and factor release [5,7]. Finally, microRNAs and other non-coding RNAs impose post-transcriptional control by targeting angiogenic mRNAs, allowing rapid adjustment of the angiogenic program in cancer and other diseases [1,2]. Together, these layers ensure that angiogenesis is tightly balanced and responsive to physiological demand.
regulation of angiogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VEGFA | Tumor angiogenesis and ischemic disease | Knockout or overexpression endothelial cell models |
| HIF1A | Hypoxia-driven cancer and vascular disorders | Point-mutation and knockout models to dissect oxygen sensing |
| FLT1 | Angiogenesis-dependent pathologies | Knock-in reporter or knockout models |
| RAP1A | Endothelial barrier and sprouting defects | Knockout and point-mutation endothelial models |
| THBS1 | Anti-angiogenic regulation in cancer | Overexpression and knockout models |
Cancer and tumor angiogenesis
Tumors frequently deregulate angiogenesis to support growth and metastasis, and non-coding RNAs including microRNAs are increasingly recognized as key regulators of this process in cancer [1,2]. Hypoxia within the tumor microenvironment stabilizes HIF factors and drives pro-angiogenic gene expression, making GO:0045765 a central node in tumor vascular biology. Targeting these regulatory pathways is a major therapeutic strategy [1,2,6].
Wound healing and cutaneous repair
Angiogenesis is essential for wound healing, and catecholamines have been shown to regulate angiogenesis in cutaneous wound healing. Peptide hormones also contribute to the regulation of vessel growth in repair contexts. Dysregulation of these signals can impair healing or lead to excessive vascularization, highlighting the clinical importance of GO:0045765 [3,4].
Vascular and ischemic disorders
In ischemic disease, insufficient angiogenesis regulation can limit tissue perfusion, whereas excessive or inappropriate angiogenesis contributes to retinopathies and inflammatory vascular disease [1,6]. The HIF system and its downstream targets are central to these responses. Understanding GO:0045765 helps identify targets for pro- or anti-angiogenic therapy [1,6].
From regulation of angiogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for angiogenesis regulation? | CRISPR knockout in endothelial cells [1,2] |
| Does a specific mutation alter angiogenic signaling? | CRISPR point-mutation knock-in [1,2] |
| How does a tagged regulator localize in endothelial cells? | Tagged knock-in [1,2] |
| Does overexpression of a factor promote angiogenesis? | CRISPR overexpression cell model [1,2] |
| Which genes modulate angiogenesis in a pooled format? | CRISPR library screening [1,2] |
| How do non-coding RNAs regulate angiogenic gene expression? | Knockout and overexpression models combined with RNA-seq [1,2] |
How to Study the regulation of angiogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global mRNA expression changes | Identify angiogenesis regulators after perturbation [1,2] |
| Small RNA-seq | MicroRNA and non-coding RNA expression | Study post-transcriptional regulation of angiogenesis [1,2] |
| HIF reporter assay | Hypoxia pathway activity | Measure oxygen-dependent angiogenesis regulation |
| Tube formation assay | Endothelial network formation | Functional readout of angiogenesis regulation [5,7] |
| Migration assay | Endothelial cell motility | Assess pro- or anti-angiogenic signals [5,8] |
| Co-culture assay | Platelet-endothelial interactions | Study platelet-mediated angiogenesis regulation |
| CRISPR library screen | Gene requirement at scale | Discover novel regulators of angiogenesis [1,2] |
| Bioinformatics pathway analysis | Enrichment of GO terms and pathways | Interpret omics data in the context of GO:0045765 [1,2] |
Transcriptomic and non-coding RNA profiling
RNA-seq and small RNA-seq are widely used to identify mRNAs and microRNAs whose expression changes during angiogenesis regulation [1,2]. These approaches help map the transcriptional and post-transcriptional layers of GO:0045765 in cancer and other settings [1,2].
Hypoxia and HIF pathway assays
Reporter assays and HIF target gene profiling are used to measure oxygen-dependent regulation of angiogenesis. Such experiments link environmental cues to the expression of pro-angiogenic factors like VEGFA.
Endothelial functional assays
Endothelial proliferation, migration, tube formation and sprouting assays are standard readouts for angiogenesis regulation [5,7,8]. These assays can be combined with genetic perturbation to test causality [5,7,8].
Platelet and hormone signaling studies
Co-culture and factor-release assays are used to study how platelets and hormones modulate endothelial behavior within GO:0045765 [3,4,7]. These methods help dissect paracrine and endocrine contributions to angiogenesis regulation [3,4,7].
How CRISPR Can Be Used to Study GO:0045765 regulation of angiogenesis
Knockout
CRISPR knockout of candidate genes in endothelial cells is used to test whether a factor is required for angiogenesis regulation [1,2]. Loss-of-function models help establish causal roles for genes such as VEGFA, HIF1A or RAP1A in vessel growth [5,6].
Point Mutation
CRISPR point-mutation knock-in allows precise modification of residues in regulators to test their functional importance [1,2]. This is particularly useful for dissecting signaling domains in receptors and GTPases involved in GO:0045765 [5,6].
Knock-in
Tagged knock-in models enable visualization and biochemical isolation of endogenous angiogenesis regulators [1,2]. Such models are valuable for studying localization and interaction partners within the angiogenic endothelium [5,7].
Overexpression
CRISPR-mediated overexpression of pro- or anti-angiogenic factors can be used to test sufficiency in angiogenesis regulation [1,2]. Overexpression models complement knockout studies and help define the directionality of regulatory effects [1,2].
How EDITGENE Supports regulation of angiogenesis Research
Researchers studying regulation of angiogenesis-related genes often need to determine whether a candidate gene is causally involved in controlling vessel growth, and at what level it acts. EDITGENE provides CRISPR-based cell model services that enable knockout, point-mutation, knock-in and overexpression studies, as well as library screening and bioinformatics support, to help dissect the regulatory networks underlying GO:0045765.
Contact EDITGENE today to design your custom CRISPR model for regulation of angiogenesis research.
Frequently Asked Questions About regulation of angiogenesis
What is GO:0045765 regulation of angiogenesis?
GO:0045765 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of angiogenesis, the formation of new blood vessels.
What genes are involved in regulation of angiogenesis?
Key genes include VEGFA, HIF1A, EPAS1, FLT1, KDR, ANGPT1, ANGPT2, TEK, PGF, FGF2, TGFB1, THBS1 and RAP1A/RAP1B, among others [4,5,6,7].
How is angiogenesis regulated by hypoxia?
Hypoxia stabilizes HIF transcription factors, which activate pro-angiogenic genes such as VEGFA, thereby increasing angiogenesis.
Do microRNAs regulate angiogenesis?
Yes, microRNAs and other non-coding RNAs regulate angiogenesis by targeting mRNAs encoding angiogenic factors and receptors, especially in cancer [1,2].
What role do platelets play in angiogenesis regulation?
Platelets release pro- and anti-angiogenic factors that act on endothelial cells, contributing to the regulation of angiogenesis.
How do catecholamines affect angiogenesis?
Catecholamines have been shown to regulate angiogenesis in cutaneous wound healing, providing neuroendocrine input to vessel growth.
What is the role of Rap1 in angiogenesis?
The small GTPase Rap1 regulates endothelial adhesion, junction formation and sprouting, thereby modulating angiogenesis.
How can CRISPR be used to study regulation of angiogenesis?
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate regulators, while library screens enable genome-wide discovery [1,2].
Which diseases involve dysregulated angiogenesis regulation?
Cancer, wound healing disorders, ischemic disease and retinopathies are among the conditions linked to altered angiogenesis regulation [1,2,3,6].
What methods are used to study GO:0045765?
Common methods include RNA-seq, small RNA-seq, HIF reporter assays, endothelial tube formation and migration assays, co-culture assays and CRISPR screens [1,2,5,6,7,8].
Conclusion
GO:0045765 regulation of angiogenesis is a central biological process term that captures the diverse mechanisms controlling new blood vessel formation. From hypoxia-driven HIF signaling to hormonal, platelet-derived and non-coding RNA inputs, this term provides a framework for understanding how angiogenesis is balanced in health and disease [1,2,3,4,5,6,7,8]. CRISPR-based cell models and screening approaches offer powerful ways to dissect these regulatory networks and to identify new therapeutic targets.
References
- 1. Su Z et al.. 2024. Regulation of Angiogenesis by Non-Coding RNAs in Cancer.. Biomolecules 14(1) PMID: 38254660
- 2. Zheng Q et al.. 2021. Regulation of angiogenesis by microRNAs in cancer.. Mol Med Rep 24(2) PMID: 34132365
- 3. Chakroborty D et al.. 2020. Catecholamines in the regulation of angiogenesis in cutaneous wound healing.. FASEB J 34(11):14093-14102 PMID: 32949437
- 4. Clapp C et al.. 2009. Peptide hormone regulation of angiogenesis.. Physiol Rev 89(4):1177-215 PMID: 19789380
- 5. Chrzanowska-Wodnicka M. 2010. Regulation of angiogenesis by a small GTPase Rap1.. Vascul Pharmacol 53(1-2):1-10 PMID: 20302970
- 6. Pugh CW et al.. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system.. Nat Med 9(6):677-84 PMID: 12778166
- 7. Walsh TG et al.. 2015. The functional role of platelets in the regulation of angiogenesis.. Platelets 26(3):199-211 PMID: 24832135
- 8. Chertok VM et al.. 2017. ENDOTELIAL-DEPENDENT OF THE REGULATION OF ANGIOGENESIS.. Tsitologiia 59(4):243-58 PMID: 30188087
